Skip to main content
. 2022 Mar 30;9:841020. doi: 10.3389/fcvm.2022.841020

Table 1.

Characteristics of acute ischemic stroke patients with atrial fibrillation.

Variable
Number of patients 16,162
Age, years, Mean ± SD 77 ± 9
Male, n (%) 8,596 (53.2)
Baseline NIHSS score, (median [IQR])* 5 (2–12)
CHA2DS2-VASc score, (median [IQR]) 4 (3–5)
Prior medical history
      Ischemic stroke/TIA, n (%) 4,544 (28.1)
      Hypertension, n (%) 13,320 (82.4)
      Diabetes, n (%) 3,118 (19.3)
      Dyslipidemia, n (%) 5,796 (35.9)
      Coronary heart disease, n (%) 3,190 (19.7)
      Smoking, n (%) 3,965 (24.5)
Reperfusion therapy, n (%) 2,919 (18.1)
Number of eligible patients for antithrombotic agents at discharge 14,838
      Antiplatelets only, n (%) 5,895 (39.7)
      Anticoagulants only, n (%) 6,061 (40.8)
      Antiplatelets and Anticoagulants, n (%) 274 (1.8)
      No-antithrombotic agent due to clear documentation of refusal or transfer to another hospital, n (%) 904 (6.1)
      No-antithrombotic agent due to unknown reasons, n (%) 1,704 (11.5)
Types of anticoagulants 6,335
      Warfarin, n (%) 2,916 (46.0)
      Direct oral anticoagulants, n (%) 3,419 (54.0)

IQR indicates interquartile range; SD, standard deviation; NIHSS, National Institutes of Health Stroke Scale; TIA, Transient ischemic attack.

*

NIHSS was available for 13,766 patients.